S100 as marker for immune effector cell-associated neurotoxicity syndrome
Wiener klinische Wochenschrift · 2025
DOI: 10.1007/s00508-024-02451-0 ↗Kurz gefasst
Fallbericht in der Zeitschrift Wiener klinische Wochenschrift, 2025. Verfasst von Axel Schulenburg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Bone Marrow Transplantation Unit, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria. axel.schulenburg@meduniwien.ac.at. Hauptthemen laut MEDLINE: Cytokine Release Syndrome, Immunotherapy, Adoptive, Neurotoxicity Syndromes, S100 Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Vienna.
Abstract (Originalsprache)
Chimeric antigen receptor (CAR)-T cell therapy is a new and successful treatment for otherwise refractory malignancies but despite the growing number of applications, this form of treatment is still associated with significant toxicity. Cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) in particular are common and dangerous side effects. This report is about two patients who received CAR‑T cell therapy and subsequently developed ICANS. This was successfully treated. During CAR‑T cell therapy, a blood marker, S100, was monitored daily. It correlated with the occurrence and progression of ICANS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bone Marrow Transplantation Unit, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria. axel.schulenburg@meduniwien.ac.at.
- Department of Medicine I, Stem Cell Transplantation Unit, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. axel.schulenburg@meduniwien.ac.at.
- Bone Marrow Transplantation Unit, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
Förderung
- Medical University of Vienna
Zitieren
APA
Schulenburg, A., Rüsing, L. Z., Bumberger, A., Mitterbauer, M., & Rabitsch, W. (2025). S100 as marker for immune effector cell-associated neurotoxicity syndrome. Wiener klinische Wochenschrift. https://doi.org/10.1007/s00508-024-02451-0
Vancouver
Schulenburg A, Rüsing LZ, Bumberger A, Mitterbauer M, Rabitsch W. S100 as marker for immune effector cell-associated neurotoxicity syndrome. Wiener klinische Wochenschrift. 2025. doi:10.1007/s00508-024-02451-0
BibTeX
@article{Schulenburg2025,
author = {Schulenburg, Axel and Rüsing, Lina Z and Bumberger, Armin and Mitterbauer, Margit and Rabitsch, Werner},
title = {S100 as marker for immune effector cell-associated neurotoxicity syndrome},
journal = {Wiener klinische Wochenschrift},
year = {2025},
doi = {10.1007/s00508-024-02451-0}
}
EUVIMED